Implementation of superior treatment regimen and improved patient pathway for neurocysticercosis in Sub-Saharan Africa

Informacje na temat projektu

NeuroSolve

Identyfikator umowy o grant: 101103306

DOI

10.3030/101103306

Data podpisania przez KE 27 Kwietnia 2023

Data rozpoczęcia 1 Maja 2023

Data zakończenia 30 Kwietnia 2027

Finansowanie w ramach

• Health

Koszt całkowity

€ 4 234 052,00

Wkład UE

€ 4 234 052,00

Koordynowany przez

R-EVOLUTION WORLDWIDE SRL - IMPRESA SOCIALE
Italy

CORDIS oferuje możliwość skorzystania z odnośników do publicznie dostępnych publikacji i rezultatów projektów realizowanych w ramach programów ramowych HORYZONT.

Odnośniki do rezultatów i publikacji związanych z poszczególnymi projektami 7PR, a także odnośniki do niektórych konkretnych kategorii wyników, takich jak zbiory danych i oprogramowanie, są dynamicznie pobierane z systemu OpenAIRE .

Rezultaty

Data Management Plan (1)

Data Management Plan

Development of Data Management Plan within the context of Task 8.3

Demonstrators, pilots, prototypes (1)

Training programme materials for researchers, clinicians and healthcare workers developed

A training programme materials for researchers, clinicians and healthcare workers is to be developed within the Task 2.2: Providing training programme for African early career researchers with African-European knowledge and student exchange opportunities for the conduct of basic research.

Documents, reports (10)

Infrastructure upgrading report

Infrastructure upgrading report as output of Task 2.4: Physical research infrastructure building/upgrading in Tanzania and Zambia.

PhD and Master’s degree students recruited

PhD and Master’s degree students recruited within the execution of Task 2.3: to provide training programme for healthcare workers involved in diagnosing and treating NCC patients in Tanzania and Zambia.

Review on serological tests

A reviewing on serological tests to be elaborated within the Task 4.1

Study initiation package

A study initiation package to be elaborated with the Task 3.1: study preparation for conducting clinical study. The registration number of the clinical study in a registry meeting WHO Registry criteria will be provided.

Publications with identified barriers

Two publications with identified barriers as outcome of Task 5.1, specifically for the health technologies: Formative research to define barriers, facilitators and implementation needs (1 publication for each country).

A publication with identified barriers for the control tools

To elaborate a publication with identified barriers for the control tools.

Risk Managment Plan (RMP)

Development of the Risk Managment Plan (RMP) within the context of Task 8.2.

Dissemination, exploitation and communication strategy plan, including communication channels and tools for advocacy

Development of a dissemination, exploitation and communication strategy plan, including communication channels and tools for advocacy as outcome of the Task 7.1.

Roadmap to policy change

A roadmap to policy change to be elaborated within the Task 6.1: Interaction with local, regional and national health agencies on study objectives, design and execution.

Monitoring and Evaluation (M&E) Plan

Development of Monitoring and Evaluation (M&E) Plan within the context of Task 8.3 (Data management, quality assurance and control, monitoring).

Websites, patent fillings, videos etc. (1)

Project website

Development of the project website within the context of Task 7.3: Development / establishment of communication channels and tools